Literature DB >> 20177918

Incidence, management, and outcome of incidental gallbladder carcinoma: analysis of the database of the Swiss association of laparoscopic and thoracoscopic surgery.

Philippe Marc Glauser1, Daniel Strub, Samuel Andreas Käser, Diana Mattiello, Franziska Rieben, Christoph Andreas Maurer.   

Abstract

BACKGROUND: Little is known about the long-term survival of patients with incidental gallbladder carcinoma (IGBC). The role of radical resection for this disease is discussed controversially in the literature. We present the long-term survival and the results of re-resection versus simple cholecystectomy of the database of the Swiss Association for Laparoscopic and Thoracoscopic Surgery (SALTS) from 1994 to 2004.
METHODS: Eighty-nine patients with histologically confirmed carcinoma of the gallbladder were identified out of 30,960 patients undergoing laparoscopic cholecystectomy. Sixty-nine patients were included in our study. Long-term survival by different T-stage and comparison of patients with extended resection versus simple cholecystectomy were calculated using the log-rank test. The time-to-event data are demonstrated by Kaplan-Meier curves.
RESULTS: The overall incidence of IGBC in patients who underwent laparoscopic cholecystectomy was 0.28% (89 of 30,960). Fifty patients underwent simple cholecystectomy [n = 2: carcinoma in situ (CIS); n = 2: pT1a; n = 10: pT1b; n = 23: pT2; n = 8: pT3; n = 5: pT4], whereas extended resection was performed in 19 cases (n = 2: pT1b; n = 11: pT2; n = 6: pT3). The comparison of simple cholecystectomy versus extended re-resection of the gallbladder bed and regional lymph node resections showed a significant benefit in overall survival for the pT2 and pT3 group (p < 0.05). The pT1b group showed no significant benefit in overall survival (p = 0.34).
CONCLUSION: IGBC has a low incidence (0.28%). We present a large study of patients with IGBC, comparing the overall survival by different histological findings. We observed a significant benefit for the group with pT2 and pT3. Therefore we recommend extended resection of the gallbladder bed and the regional lymph nodes for patient with incidental histologically confirmed pT2 and pT3 carcinoma of the gallbladder after performance of laparoscopic cholecystectomy. For patients with pT1b stage no recommendations can be given based on this study.

Entities:  

Mesh:

Year:  2010        PMID: 20177918     DOI: 10.1007/s00464-010-0952-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Early gallbladder carcinoma does not warrant radical resection.

Authors:  T Wakai; Y Shirai; N Yokoyama; S Nagakura; H Watanabe; K Hatakeyama
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

Review 2.  Incidental carcinoma of the gallbladder.

Authors:  S Varshney; G Butturini; G Buttirini; R Gupta
Journal:  Eur J Surg Oncol       Date:  2002-02       Impact factor: 4.424

3.  Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.

Authors:  Jason M Foster; Hisakazu Hoshi; John F Gibbs; Renuka Iyer; Miland Javle; Quyen Chu; Boris Kuvshinoff
Journal:  Ann Surg Oncol       Date:  2006-11-11       Impact factor: 5.344

4.  Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma.

Authors:  S Kondo; Y Nimura; N Hayakawa; J Kamiya; M Nagino; K Uesaka
Journal:  Br J Surg       Date:  2000-04       Impact factor: 6.939

5.  Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy.

Authors:  Toshifumi Wakai; Yoshio Shirai; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2002-04-18       Impact factor: 3.352

6.  [S3-guidelines for diagnosis and treatment of gallstones. German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract].

Authors:  F Lammert; M W Neubrand; R Bittner; H Feussner; L Greiner; F Hagenmüller; K H Kiehne; K Ludwig; H Neuhaus; G Paumgartner; J F Riemann; T Sauerbruch
Journal:  Z Gastroenterol       Date:  2007-09       Impact factor: 2.000

7.  Unsuspected gallbladder cancer diagnosed during or after laparoscopic cholecystectomy.

Authors:  A-Hon Kwon; Atsushi Imamura; Hiroaki Kitade; Yasuo Kamiyama
Journal:  J Surg Oncol       Date:  2008-03-01       Impact factor: 3.454

8.  A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.

Authors:  Renuka V Iyer; John Gibbs; Boris Kuvshinoff; Marwan Fakih; James Kepner; Nancy Soehnlein; David Lawrence; Milind M Javle
Journal:  Ann Surg Oncol       Date:  2007-08-19       Impact factor: 5.344

9.  The surgical treatment for carcinoma of the gallbladder--rationale of the second-look operation for inapparent carcinoma.

Authors:  T Tsunoda; R Tsuchiya; N Harada; K Izawa; T Yamaguchi; K Yamamoto; K Motoshima; T Tomioka; S Matsuo; T Eto
Journal:  Jpn J Surg       Date:  1987-11

Review 10.  Carcinoma of the gall-bladder: an experience and review of the literature.

Authors:  D S Wilkinson
Journal:  Aust N Z J Surg       Date:  1995-10
View more
  18 in total

1.  Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer.

Authors:  T Tsirlis; F Ausania; S A White; J J French; B C Jaques; R M Charnley; D M Manas
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

2.  Outcome of Surgical Inspection of the Gallbladder in Relation to Final Pathology.

Authors:  B J G A Corten; S Alexander; P H van Zwam; W K G Leclercq; R M H Roumen; G D Slooter
Journal:  J Gastrointest Surg       Date:  2018-08-21       Impact factor: 3.452

Review 3.  Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis.

Authors:  Kui Sun Choi; Sae Byeol Choi; Pyoungjae Park; Wan Bae Kim; Sang Yong Choi
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Incidental gallbladder carcinoma: our experience.

Authors:  A Panebianco; A Volpi; C Lozito; A Prestera; P Ialongo; N Palasciano
Journal:  G Chir       Date:  2013 May-Jun

5.  Does Anatomic Resection Get More Benefits than Wedge Hepatectomy on the Prognosis for pT3 Unsuspected Gallbladder Cancer?

Authors:  Liang-He Yu; Bo Yuan; Xiao-Hui Fu; Wen-Long Yu; Jian Liu; Yong-Jie Zhang
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2019-08-12       Impact factor: 1.878

6.  Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3 months prior to a radical resection.

Authors:  Fabio Ausania; Theodoris Tsirlis; Steven A White; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

7.  Unsuspected gallbladder carcinoma discovered during or after cholecystectomy: focus on appropriate radical re-resection according to the T-stage.

Authors:  X Yi; X Long; H Zai; D Xiao; W Li; Y Li
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

8.  Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer.

Authors:  Jean M Butte; T Peter Kingham; Mithat Gönen; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-05-16       Impact factor: 6.113

9.  Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre.

Authors:  Vincent S Yip; Dhanwant Gomez; Sean Brown; Clare Byrne; David White; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  HPB (Oxford)       Date:  2013-11-27       Impact factor: 3.647

10.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.